Advantages of the Liposomal Form of Xymedon in Leukopoiesis Restoration against the Background of Myelosuppressive Therapy with Liposomal Antineoplastic Drugs in Experiment
Crossref DOI link: https://doi.org/10.1007/s10517-021-05362-6
Published Online: 2021-12-02
Published Print: 2021-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Siprov, A. V.
Solov’eva, M. A.
Zemskova, S. E.
Text and Data Mining valid from 2021-12-01
Version of Record valid from 2021-12-01
Article History
Received: 20 May 2021
First Online: 2 December 2021